ExCellThera announces completion of Phase 2 clinical trials for UM171-expanded cell therapy in high-risk blood cancers November 15, 2022 Read More »
Beam Therapeutics Enrolls First Patient in BEACON Clinical Trial of BEAM-101 Base Editing Therapy Candidate for the Treatment of Sickle Cell Disease November 14, 2022 Read More »
BrainStorm Cell Therapeutics Receives Refusal to File Letter from FDA for its New Biologics License Application for NurOwn for the treatment of ALS November 10, 2022 Read More »
Grant Awarded to Develop Genetically Engineered Stem Cell Products to Fight Gastroesophageal Cancer November 9, 2022 Read More »
ExCellThera announces 100th patient treated with UM171-expanded cell therapy November 8, 2022 Read More »
Stem Cell Clinical Trials and New Therapies for Patients: Alpha Clinic Director’s Panel November 7, 2022 Read More »
Global Stem Cells Market to Generate Revenue of $25.68 Billion By 2028 | More than 80% of Revenue Comes from Adult Stem Cells November 2, 2022 Read More »
